Search

Displaying results 9421 - 9430 of 10000 in total
  1. Drug

    Blisibimod

    go.drugbank.com/drugs/DB12330
    Investigational

    Blisibimod has been used in trials studying the treatment of IgA Nephropathy, Microscopic Polyangiitis, Systemic Lupus Erythematosus, and Granulomatosis With Polyangiitis.

  2. Drug

    CPG-52852

    go.drugbank.com/drugs/DB12476
    Investigational

    852A has been used in trials studying the treatment of Melanoma, Neoplasms, Breast Cancer, Ovarian Cancer, and Cervical Cancer, among others.

    Synonyms: N-[4-(4-amino-2-ethylimidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide
  3. Drug

    Isopentyl 2-cyanoacrylate

    go.drugbank.com/drugs/DB12630
    Experimental

    Isoamyl 2 Cyanoacrylate is under investigation in clinical trial NCT02698644 (Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate).

  4. Drug

    Daporinad

    go.drugbank.com/drugs/DB12731
    Investigational

    Daporinad has been used in trials studying the treatment of Melanoma, Cutaneous T-cell Lymphoma, and B-cell Chronic Lymphocytic Leukemia.

  5. Drug

    Larotaxel

    go.drugbank.com/drugs/DB12984
    Investigational

    Larotaxel has been used in trials studying the treatment of Cancer, Metastases, Breast Cancer, Breast Neoplasms, and Pancreatic Neoplasms, among others.

  6. Drug

    TNP-470

    go.drugbank.com/drugs/DB08633
    Investigational

    O-(chloroacetylcarbamoyl)fumagillol (TNP-470) has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, and Pancreatic Neoplasms.

  7. Drug

    Dinalbuphine sebacate

    go.drugbank.com/drugs/DB15341
    Investigational

    Dinalbuphine sebacate is under investigation in clinical trial NCT02468128 (A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management).

  8. Drug

    Cobalt Co-60

    go.drugbank.com/drugs/DB15374
    Experimental

    Cobalt Co-60 is under investigation in clinical trial NCT02891083 (Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer).

  9. Drug

    LV305

    go.drugbank.com/drugs/DB17288
    Investigational

    LV305 is an active component of CMB305 along with [G305].[L47346]

  10. Drug

    QR-313

    go.drugbank.com/drugs/DB17867
    Investigational

    QR-313 is an antisense oligonucleotide targeting exon 73. It is being investigated for the treatment of dystrophic epidermolysis bullosa.[A259867]